DEVERSIFY SELECTED FOR EIT HEALTH’S BRIDGEHEAD PROGRAMME 2022
Deversify AB is a Swedish health tech company offering solutions for improved individual health and wellbeing. The company has been handpicked as one of 29 start-ups and scale-ups to participate in the prestigious Bridgehead Programme. Bridgehead serves to support promising health companies in gaining crucial connections and experience through EIT Health’s vast and diverse network.
”Bridgehead is a dream opportunity for us to build presence in more European countries and ultimately, through this impressive network, to improve health beyond any borders. We are particularly proud to be the only Swedish company selected this year and will announce more details about which international markets we will focus on as part of the programme in due time. Bridgehead means a world of new opportunities for us!”, says Deversify’s CEO and Co-Founder Anders Murman.
Deversify is a Swedish R&D company offering healthtech solutions for consumers. We develop and commercialise mobile electronic devices and apps to monitor biomarkers for individualised health, specialising in breathalysers. We also develop and provide education services regarding metabolic health and personalised nutrition.
Our vision is that everyone should understand their own health. Deversify’s goal is to be the leading provider of consumer health products for improved fact-based wellbeing globally.
Anders Murman, CEO
+46 70 546 50 62